Henry Schein, Inc. (HSIC) Reaches $67.48 After 3.00% Up Move; Medequities Realty Trust (MRT) Sellers Decreased By 1.04% Their Shorts

November 15, 2017 - By Henry Gaston

The stock of Henry Schein, Inc. (NASDAQ:HSIC) is a huge mover today! About 543,622 shares traded. Henry Schein, Inc. (NASDAQ:HSIC) has risen 4.05% since November 15, 2016 and is uptrending. It has underperformed by 12.65% the S&P500.The move comes after 6 months positive chart setup for the $10.59 billion company. It was reported on Nov, 15 by Barchart.com. We have $69.50 PT which if reached, will make NASDAQ:HSIC worth $317.70M more.

Medequities Realty Trust Incorporated (NYSE:MRT) had a decrease of 1.04% in short interest. MRT’s SI was 142,900 shares in November as released by FINRA. Its down 1.04% from 144,400 shares previously. With 191,500 avg volume, 1 days are for Medequities Realty Trust Incorporated (NYSE:MRT)’s short sellers to cover MRT’s short positions. About 19,450 shares traded. MedEquities Realty Trust Inc (NYSE:MRT) has 0.00% since November 15, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 7 analysts covering MedEquities Realty (NYSE:MRT), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. MedEquities Realty had 7 analyst reports since October 24, 2016 according to SRatingsIntel. The firm has “Mkt Outperform” rating by JMP Securities given on Monday, October 24. The firm has “Outperform” rating by FBR Capital given on Monday, October 24. The rating was initiated by RBC Capital Markets on Monday, October 24 with “Outperform”. Raymond James initiated the shares of MRT in report on Monday, October 24 with “Outperform” rating. The rating was initiated by JP Morgan on Monday, October 24 with “Neutral”. The rating was initiated by KeyBanc Capital Markets with “Overweight” on Monday, November 14. The company was initiated on Monday, October 24 by Citigroup.

MedEquities Realty Trust, Inc. is a real estate investment trust . The company has market cap of $337.25 million. The Firm invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. It has a 27.05 P/E ratio. The Firm invests primarily in real estate across the acute and post-acute spectrum of care.

Among 18 analysts covering Henry Schein Inc. (NASDAQ:HSIC), 9 have Buy rating, 0 Sell and 9 Hold. Therefore 50% are positive. Henry Schein Inc. had 37 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, July 5 by Stifel Nicolaus. PiperJaffray upgraded Henry Schein, Inc. (NASDAQ:HSIC) rating on Friday, September 15. PiperJaffray has “Overweight” rating and $193 target. The firm earned “Hold” rating on Friday, July 31 by Evercore. Leerink Swann maintained the shares of HSIC in report on Tuesday, November 7 with “Market Perform” rating. The stock of Henry Schein, Inc. (NASDAQ:HSIC) has “Buy” rating given on Tuesday, November 7 by Robert W. Baird. Jefferies maintained the stock with “Hold” rating in Tuesday, August 22 report. The firm has “Buy” rating given on Thursday, October 26 by Piper Jaffray. Gabelli upgraded the shares of HSIC in report on Tuesday, January 10 to “Buy” rating. The stock has “Hold” rating by Stifel Nicolaus on Tuesday, October 17. The stock has “Hold” rating by Stifel Nicolaus on Tuesday, August 8.

Analysts await Henry Schein, Inc. (NASDAQ:HSIC) to report earnings on February, 20. They expect $0.97 EPS, up 3.19% or $0.03 from last year’s $0.94 per share. HSIC’s profit will be $152.23 million for 17.39 P/E if the $0.97 EPS becomes a reality. After $0.87 actual EPS reported by Henry Schein, Inc. for the previous quarter, Wall Street now forecasts 11.49% EPS growth.

Henry Schein, Inc. is a provider of healthcare services and products primarily to office dental, animal health and medical practitioners. The company has market cap of $10.59 billion. The Firm operates through two divisions: healthcare distribution, and technology and value-added services. It has a 19.43 P/E ratio. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Investors sentiment increased to 1.16 in 2017 Q2. Its up 0.25, from 0.91 in 2017Q1. It improved, as 31 investors sold Henry Schein, Inc. shares while 164 reduced holdings. 60 funds opened positions while 166 raised stakes. 68.82 million shares or 1.55% less from 69.91 million shares in 2017Q1 were reported. Pensionfund Dsm Netherlands holds 0.52% in Henry Schein, Inc. (NASDAQ:HSIC) or 18,500 shares. Edgestream Ptnrs Lp invested in 0.15% or 2,114 shares. Montecito Financial Bank holds 1,350 shares. Rothschild Asset Management stated it has 2,757 shares or 0.01% of all its holdings. Suntrust Banks has 0.01% invested in Henry Schein, Inc. (NASDAQ:HSIC) for 11,864 shares. Champlain Inv Partners Lc accumulated 365,355 shares. Utd Automobile Association has 42,093 shares. 360,195 were reported by Bamco. Fil Limited owns 74,230 shares for 0.04% of their portfolio. Btim holds 1,425 shares or 0% of its portfolio. Stephens Ar has 2,379 shares for 0.01% of their portfolio. Aberdeen Asset Mgmt Public Limited Uk reported 24,345 shares stake. Eqis Capital Mgmt Inc has 1,755 shares. North Point Portfolio Managers Corp Oh holds 3.54% in Henry Schein, Inc. (NASDAQ:HSIC) or 111,040 shares. Regentatlantic Cap Limited Co owns 5,036 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com